Skip to main content
. 2021 Oct 18;9:724282. doi: 10.3389/fcell.2021.724282

FIGURE 2.

FIGURE 2

Downregulation of ALKBH5 in PDAC predicts poor prognosis. (A) Log-rank analysis of correlation between overall survival (OS) and the expression of each m6A regulator in tumor. (B,C) Log-rank analysis of correlation between OS or progression-free survival (PFS) and the expression of m6A regulators in stroma. (D–G) Kaplan–Meier analysis of correlation between OS or PFS and ALKBH5, FTO, and YTHDF1 protein expression. (H,I) Cox regression analysis for OS in PDAC patients. *P < 0.05.